Log in to save to my catalogue

Performance Characteristics of DOAC-Remove for Neutralization of the Effects of Apixaban and Rivarox...

Performance Characteristics of DOAC-Remove for Neutralization of the Effects of Apixaban and Rivarox...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2586456406

Performance Characteristics of DOAC-Remove for Neutralization of the Effects of Apixaban and Rivaroxaban in Lupus Anticoagulant Assays

About this item

Full title

Performance Characteristics of DOAC-Remove for Neutralization of the Effects of Apixaban and Rivaroxaban in Lupus Anticoagulant Assays

Publisher

US: Oxford University Press

Journal title

American journal of clinical pathology, 2022-03, Vol.157 (3), p.457-469

Language

English

Formats

Publication information

Publisher

US: Oxford University Press

More information

Scope and Contents

Contents

Abstract
Objectives
This study established the performance characteristics of DOAC-Remove for neutralization of the effects of rivaroxaban and apixaban in lupus anticoagulant (LAC) testing.
Methods
Normal donor, LAC control, and patient samples were spiked with rivaroxaban or apixaban to simulate their effects on the dilute Russell’s vi...

Alternative Titles

Full title

Performance Characteristics of DOAC-Remove for Neutralization of the Effects of Apixaban and Rivaroxaban in Lupus Anticoagulant Assays

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2586456406

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2586456406

Other Identifiers

ISSN

0002-9173

E-ISSN

1943-7722

DOI

10.1093/ajcp/aqab149

How to access this item